Group Management

    The Board of Directors has in accordance with its guidelines and instructions assigned to the Company’s CEO to manage the Company’s affairs. The CEO, and the Executive Management under the supervision of the CEO, are responsible for the Group’s day-to-day business and management. The CEO regularly reports to the Board of Directors on how the Company’s business performs, financial results, and other important issues.

    Torben Jørgensen

    CEO and President

    The Board of Directors appointed Torben Jørgensen as the CEO and President of Biotage, effective as of January 4th, 2024. Torben served as the CEO and President of Biotage from 2006 to 2019. Prior to this appointment, he served as the Chairman of the Biotage Board, and he will continue as a Board member while taking on the role of interim CEO and President. From 2019 onwards, Torben has been acting as an advisor and board member within the life sciences industry. Currently, he serves as the Chairman of the Board for Genovis AB and Boule Diagnostics AB and is a Board Member of Advanced Instruments, Inc.

    Andrew Kellett

    Chief Financial Officer

    Andrew Kellett is the CFO at Biotage as of September 25th 2023.  Andrew has a strong track record in the financial and operational leadership of international science and technology growth companies. Most recently, Andrew was the CFO of Technetix Group, an international technology business. His previous roles have included CFO of Genetix PLC, a publicly listed business, here he played a key role in the growth, transformation, and successful sale of the company to the Danaher Corporation. He also held CFO positions at Cmed Group, an international CRO and the Global Controller of the Clinical Trials and Pharmaceutical Development business of Quest Diagnostics, a fortune 500 company. Andrew is a Chartered Accountant having qualified with Coopers and Lybrand.